EIKN ▼ -1.5% - Eikon Therapeutics, Inc. $EIKN - Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer Eikon Therapeutics shares fell 1.5% today following the company's announcement that it has appointed Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer. The appointment appears not to have resonated positively with investors on the day of announcement. 03-SEP-2026 07:30 AM ET